Suchergebnisse - "Tung, Nadine M"

PubPharm (93)

1

Identifying homologous recombination deficiency in breast cancer : genomic instability score distributions differ among breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2023

von Lenz, L. | Neff, C. | Solimeno, C. | +27

2

Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature

enthalten in: JCO precision oncology | 2023

von Batalini, F. | Madison, R. | Sokol, E. | +10

3

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2023

von Lenz, L. | Neff, C. | Solimeno, C. | +27

4

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

enthalten in: Breast cancer research and treatment | 2023

von Lenz, L. | Neff, C. | Solimeno, C. | +27

5

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

enthalten in: JCO precision oncology | 2023

von Desai, N. | Barrows, E. | Nielsen, S. | +8

6

Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer : Single-Arm Prospective Clinical Trial

enthalten in: Journal of the American College of Surgeons | 2023

von Weiss, A. | Li, T. | Desai, N. | +20

CommentIn: J Am Coll Surg. 2023 Aug 1;237(2):256-258. - PMID 37199440

7

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer : Evidence and Controversies

enthalten in: The oncologist | 2023

von Morganti, S. | Bychkovsky, B. | Poorvu, P. | +10

8

Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab

enthalten in: JAMA oncology | 2023

von Waks, A. | Ogayo, E. | Paré, L. | +20

9

The risks of cancer in older women with BRCA pathogenic variants : How far have we come?

enthalten in: Cancer | 2023

von Metcalfe, K. | Gronwald, J. | Tung, N. | +20

10

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Batalini, F. | Gulhan, D. | Mao, V. | +16

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]